Clinical trials
Phase 1/2 Multiple Sclerosis, Chronic Progressive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Johns Hopkins University | 2 |
| AbelZeta Inc. | 1 |
| Atara Biotherapeutics | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Opexa Therapeutics, Inc. | 1 |
| Tr1X, Inc. | 1 |
| University of California, San Francisco | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 12 |
| Multiple Sclerosis | 8 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Autoimmune Diseases | 1 |
| Demyelinating Diseases | 1 |
| Epstein-Barr Virus Infections | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.